SCHEMBL16112970

SCHEMBL16112970

c1ncnc(-c2nccs2)n1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDPK1 O15530 1/20 0.45
CYP2A6 P11509 1/20 0.44
ADORA2A P29274 3/20 0.43
LOXL2 Q9Y4K0 1/20 0.39
ALDH1A1 P00352 2/20 0.39
TSHR P16473 1/20 0.39
NOS1 P29475 1/20 0.39
HSD17B10 Q99714 1/20 0.39
HSP90AA1 P07900 1/20 0.38
RAB9A P51151 5/20 0.38
NPC1 O15118 4/20 0.38
PKM P14618 2/20 0.38
KMT2A Q03164 2/20 0.38
RECQL P46063 1/20 0.38
ADRB2 P07550 1/20 0.36
FBP1 P09467 1/20 0.36
PDK1 Q15118 1/20 0.36
SMPD3 Q9NY59 1/20 0.35
KDM4E B2RXH2 1/20 0.35
MEN1 O00255 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL556950 0.80 PDPK1 (0.54) PDPK1CYP2A6ADORA2ALOXL2ALDH1A1
SCHEMBL102331 0.76 PDPK1 (0.59) PDPK1CYP2A6ADORA2ALOXL2ALDH1A1
SCHEMBL17701190 0.74 PDPK1 (0.43) PDPK1CYP2A6ADORA2ALOXL2ALDH1A1
SCHEMBL30632310 0.73 PDPK1 (0.56) PDPK1CYP2A6ADORA2ALOXL2ALDH1A1
SCHEMBL28154527 0.73 PDPK1 (0.56) PDPK1CYP2A6ADORA2ALOXL2ALDH1A1
SCHEMBL31556353 0.73 PDPK1 (0.56) PDPK1CYP2A6ADORA2ALOXL2ALDH1A1
SCHEMBL30534095 0.73 PDPK1 (0.56) PDPK1CYP2A6ADORA2ALOXL2ALDH1A1
SCHEMBL26635219 0.73 ADORA2A (0.49) PDPK1CYP2A6ADORA2ALOXL2ALDH1A1
SCHEMBL16369869 0.73 PDPK1 (0.38) PDPK1CYP2A6ADORA2ALOXL2ALDH1A1
SCHEMBL3093510 0.71 HSP90AA1 (0.52) PDPK1CYP2A6LOXL2HSP90AA1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110404418-A A kind of antibacterial ultrafiltration membrane and preparation method thereof LIU SHANMING 2019-11-05 CN claimed
EP-3686190-A1 SYNTHESIS OF THERAPEUTICALLY ACTIVE COMPOUNDS Agios Pharmaceuticals, Inc. (US) 2020-07-29 EP disclosed
CN-110404418-A A kind of antibacterial ultrafiltration membrane and preparation method thereof LIU SHANMING 2019-11-05 CN disclosed
CN-110404418-A A kind of antibacterial ultrafiltration membrane and preparation method thereof LIU SHANMING 2019-11-05 CN disclosed
CN-110372753-A Electroluminescent organic material and device 环球展览公司 2019-10-25 CN disclosed
CN-110256499-A Electroluminescent organic material and device 环球展览公司 2019-09-20 CN disclosed
CN-110128479-A Electroluminescent organic material and device 环球展览公司 2019-08-16 CN disclosed
CN-110078740-A Electroluminescent organic material and device 环球展览公司 2019-08-02 CN disclosed
CN-110003244-A Thiazole triazin compound and its application containing trifluoromethyl benzyl 沈阳药科大学 2019-07-12 CN disclosed
CN-110003244-A Thiazole triazin compound and its application containing trifluoromethyl benzyl 沈阳药科大学 2019-07-12 CN disclosed
CN-103732065-B For treating the benzofuran compound of infection with hepatitis C virus 葛兰素集团有限公司 2016-10-26 CN disclosed
CN-104334535-B Dendrimer-like aminoamides with sodium channel blocking activity for the treatment of dry eye and other mucosal diseases 帕里昂科学公司 2016-10-05 CN disclosed
CN-105859598-A Preparation method of polysubstituted dithioaryl imine derivative 青岛科技大学 2016-08-17 CN disclosed
EP-3019483-A1 THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE Agios Pharmaceuticals, Inc. (US) 2016-05-18 EP disclosed
EP-2970107-A1 PHOTOSWITCHABLE HDAC INHIBITORS The General Hospital Corporation (US) 2016-01-20 EP disclosed
US-20150279654-A1 TREATING SOLUTION FOR ELECTRONIC PARTS, AND PROCESS FOR PRODUCING ELECTRONIC PARTS FINE POLYMERS CORPORATION (JP) 2015-10-01 US disclosed
CN-104334535-A Dendrimer-like aminoamides with sodium channel blocking activity for the treatment of dry eye and other mucosal diseases PARION SCIENCES INC 2015-02-04 CN disclosed
WO-2015003640-A1 THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE AGIOS PHARMACEUTICALS, INC. (US) 2015-01-15 WO disclosed
WO-2014160221-A1 PHOTOSWITCHABLE HDAC INHIBITORS THE GENERAL HOSPITAL CORPORATION (US) 2014-10-02 WO disclosed
CN-103732065-A Benzofuran compounds for the treatment of hepatitis c virus infections GLAXO GROUP LTD 2014-04-16 CN disclosed